2FIRSTS | WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
Summary
A WIRED investigation reveals that manufacturers are increasingly using nicotine analogs, such as 6-methyl-nicotine, to bypass U.S. regulatory frameworks. These compounds resemble nicotine in structure and effect but may fall outside current legal definitions. While some research suggests these analogs could be more potent or addictive than traditional nicotine, the long-term health impacts on humans remain largely unknown.
This shift comes as U.S. regulators attempt to tighten oversight of synthetic nicotine. While some states have already expanded their tobacco definitions, federal policymakers are considering broader definitions to include these analogs under FDA oversight. This movement marks a shift in regulation from focusing on products to scrutinizing specific chemical compositions.
Data from 2Firsts highlights the scale of this trend, noting a massive 234.7% surge in 6-methyl nicotine-related products in exports from China to the U.S. in the first half of 2026. As companies seek ways to navigate evolving rules, the industry faces increasing pressure regarding ingredient transparency and compliance.
(Source:2Firsts)